These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24436040)

  • 1. The role of the pathologist in GLP studies.
    Weber K; Hailey JR; Mann PC; Seaton M; Funk KA
    Toxicol Pathol; 2014 Jan; 42(1):275. PubMed ID: 24436040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the study pathologist.
    Weber K
    Toxicol Pathol; 2014 Jan; 42(1):276-7. PubMed ID: 24334675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory forum opinion piece: Peer review documentation and pathology data locking.
    Neef N
    Toxicol Pathol; 2014; 42(2):311-3. PubMed ID: 24357644
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathology working groups.
    Mann PC; Hardisty JH
    Toxicol Pathol; 2014 Jan; 42(1):283-4. PubMed ID: 24190914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The study pathologist's role in GLP studies: a regulator's perspective.
    Seaton M
    Toxicol Pathol; 2014 Jan; 42(1):285. PubMed ID: 24178580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A brief overview of the 33rd Annual STP Symposium on the translational pathology: relevance of toxicologic pathology to human health.
    Hoenerhoff MJ; Silverman L; Francke S
    Toxicol Pathol; 2015 Jan; 43(1):41-7. PubMed ID: 25351921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peer review in toxicologic pathology.
    Ward JM; Hardisty JF; Hailey JR; Streett CS
    Toxicol Pathol; 1995; 23(2):226-34. PubMed ID: 7569679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Society of Toxicologic Pathology position paper on best practices on recovery studies: the role of the anatomic pathologist.
    Perry R; Farris G; Bienvenu JG; Dean C; Foley G; Mahrt C; Short B;
    Toxicol Pathol; 2013; 41(8):1159-69. PubMed ID: 23531793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Severity Grades to Characterize Histopathologic Changes.
    Schafer KA; Eighmy J; Fikes JD; Halpern WG; Hukkanen RR; Long GG; Meseck EK; Patrick DJ; Thibodeau MS; Wood CE; Francke S
    Toxicol Pathol; 2018 Apr; 46(3):256-265. PubMed ID: 29529947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global recognition of qualified toxicologic pathologists: credential review as a potential route for recognizing the proficiency of pathologists involved in regulatory-type nonclinical studies.
    Ettlin RA; Bolon B; Pyrah I; Konishi Y; Black HE
    Toxicol Pathol; 2009 Jun; 37(4):553-61. PubMed ID: 19458391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global recognition of qualified toxicologic pathologists: credential review as a potential route for recognizing the proficiency of pathologists involved in regulatory-type nonclinical studies.
    Ettlin RA; Bolon B; Pyrah I; Konishi Y; Black HE
    Exp Toxicol Pathol; 2010 Jul; 62(4):413-22. PubMed ID: 19604680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory forum opinion piece: blind reading of histopathology slides in general toxicology studies.
    Neef N; Nikula KJ; Francke-Carroll S; Boone L
    Toxicol Pathol; 2012 Jun; 40(4):697-9. PubMed ID: 22407309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the peer review pathologist in good laboratory practices studies: a sponsor perspective.
    Hailey JR
    Toxicol Pathol; 2014 Jan; 42(1):278-82. PubMed ID: 24178581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peer review in toxicologic histopathology: its necessity, type and procedure].
    Yoshitomi K
    J Toxicol Sci; 1998 May; 23 Suppl 1():1-9. PubMed ID: 9617732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies.
    Bolon B; Barale-Thomas E; Bradley A; Ettlin RA; Franchi CA; George C; Giusti AM; Hall R; Jacobsen M; Konishi Y; Ledieu D; Morton D; Park JH; Scudamore CL; Tsuda H; Vijayasarathi SK; Wijnands MV
    Exp Toxicol Pathol; 2011 Jan; 63(1-2):187-95. PubMed ID: 20724123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for pathology peer review.
    Morton D; Sellers RS; Barale-Thomas E; Bolon B; George C; Hardisty JF; Irizarry A; McKay JS; Odin M; Teranishi M
    Toxicol Pathol; 2010 Dec; 38(7):1118-27. PubMed ID: 20924082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the toxicologic pathologist in the biopharmaceutical industry.
    van Tongeren S; Fagerland JA; Conner MW; Diegel K; Donnelly K; Grubor B; Lopez-Martinez A; Bolliger AP; Sharma A; Tannehill-Gregg S; Turner PV; Wancket LM
    Int J Toxicol; 2011 Oct; 30(5):568-82. PubMed ID: 21878555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory forum opinion piece: the role of the toxicologic pathologist in the postgenomic era: challenges and opportunities.
    Maronpot RR
    Toxicol Pathol; 2012 Oct; 40(7):1082-6. PubMed ID: 22585943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scientific and Regulatory Policy Committee Review: Review of the Organisation for Economic Co-operation and Development (OECD) Guidance on the GLP Requirements for Peer Review of Histopathology.
    Fikes JD; Patrick DJ; Francke S; Frazier KS; Reindel JF; Romeike A; Spaet RH; Tomlinson L; Schafer KA;
    Toxicol Pathol; 2015 Oct; 43(7):907-14. PubMed ID: 26208968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Society of Toxicologic Pathology position on histopathology data collection and audit trail: compliance with 21 CFR parts 58 and 11.
    Tuomari D; Elliott G; Kulwich B; Yarrington J; Fouillet X; Geoly F; Long P
    Toxicol Pathol; 2004; 32(1):122-3. PubMed ID: 14713556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.